13726-17-5

Basic information

• Product Name: (4-Chloro-3-Methoxyphenyl)Methanol
• Synonyms: (4-Chloro-3-Methoxyphenyl)Methanol;4-Chloro-3-methoxybenzyl alcohol
• CAS NO: 13726-17-5
• Molecular Formula: C₈H₉ClO₂
• Molecular Weight: 172.60886
• Mol File: 13726-17-5.mol
• Article Data: 15

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: (4-Chloro-3-Methoxyphenyl)Methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (4-Chloro-3-Methoxyphenyl)Methanol(13726-17-5)
• EPA Substance Registry System: (4-Chloro-3-Methoxyphenyl)Methanol(13726-17-5)

Safety Data

• Hazardous Substances Data: 13726-17-5(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Journal of Medicinal Chemistry, 32, p. 1757, 1989 DOI: 10.1021/jm00128a016

Upstream product

• 97-52-9 2-methoxy-4-nitrophenylamine 
• 615-74-7 2-chloro-5-methylphenol 
• 77-78-1 dimethyl sulfate 
• 116022-18-5 methyl 4-chloro-3-methoxybenzoate 
• 85740-98-3 4-chloro-3-methoxybenzoic acid 
• 13726-14-2 4-chloro-m-anisidine 
• 1009-36-5 2-chloro-5-nitroanisole 
• 73909-16-7 2-chloro-5-methylanisole 
• 56962-12-0 3-hydroxy-4-chlorobenzaldehyde 
• 13726-16-4 4-chloro-3-methoxybenzaldehyde 

Downstream Products

• 96495-22-6 2-(4-chloro-3-methoxyphenyl)ethylamine 
• 144181-28-2 1-chloro-2-methoxy-4-(2-nitrovinyl)benzene 
• 144181-29-3 N-propionyl-2-(4-chloro-3-methoxyphenyl)ethylamine 
• 144181-30-6 N-(phenylacetyl)-2-(4-chloro-3-methoxyphenyl)ethylamine 
• 144181-31-7 N-<(3-methoxyphenyl)acetyl>-2-(4-chloro-3-methoxyphenyl)ethylamine 
• 144181-32-8 N-<(4-methoxyphenyl)acetyl>-2-(4-chloro-3-methoxyphenyl)ethylamine 
• 144181-33-9 N-<3-(4-methoxyphenyl)propionyl>-2-(4-chloro-3-methoxyphenyl)ethylamine 
• 1350473-74-3 4-(3-(4-chloro-3-methoxyphenyl)-1H-pyrazol-4-yl)pyridine 
• 85740-98-3 4-chloro-3-methoxybenzoic acid 

Relevant articles and documents

Evaluation of the inhibitory effects of pyridylpyrazole derivatives on lps-induced pge2 productions and nitric oxide in murine raw 264.7 macrophages

A series of thirteen triarylpyrazole analogs were investigated as inhibitors of lipopolysaccharide (LPS)-induced prostaglandin E2 (PGE2 ) and nitric oxide (NO) production in RAW 264.7 macrophages. The target compounds 1a–m have first

Preparation of (2E,4E)-2-(2-benzyloxyethyl)-5-(3-methoxy-4-chlorophenyl) penta-2,4-dienal as a key intermediate in the synthesis of strobilurin B

(2E,4E)-2-(2-Benzyloxyethyl)-5-(4-chloro-3-methoxyphenyl)penta-2,4-dienal was obtained by the condensation of 4-benzyloxybutanal N-tert-butylimine with 4-chloro-3-methoxycinnamic aldehyde with ≥98% configurational purity and 40% yield. When 4-benzyloxy-2-triethylsilylbutanal imine was used, a 7: 3 mixture of the target (2E,4E)-dienal with its (2Z,4E)-isomer was obtained in 60% yield; the latter quantitatively isomerized to the thermodynamically preferable target (2E,4E)-dienal.

ARYLACETATE DERIVATIVE HAVING ISOXAZOLE SKELETON

A compound of the formula (I): pharmaceutically acceptable salt or solvate thereof, wherein Y is a group of the formula: wherein Ring A is optionally substituted aryl or optionally substituted heteroaryl, X3 is COOR17 or the like Y i